Last updated on: 11/13/2008 | Author:

Gary I. Wadler, MD Biography

Chairman of the World Anti-Doping Agency's (WADA) Prohibited List and Methods Sub-Committee
Con to the question "Should Performance-Enhancing Drugs Be Accepted in Sports?"

“For the past 15 years, I have attempted to focus attention on the cascading problem of drugs in sports.
Drug testing is at a crossroads…the point where everyone agrees--at last that something must be done…

Doping is a matter of ethics, which affects not only Olympic athletes but also youth, high school, college and professional athletes. The fact is doping threatens to undermine the ethical and physical well being of children…

Clearly most athletes, especially Olympic athletes, serve as positive role models, shaping the behavior of our youth. Regrettably, there is a negative ripple effect from those who resort to doping…

We cannot allow performance-enhancing drugs to undermine the Olympic Movement. We cannot allow another generation of young people to approach adulthood with a pervading sense of cynicism, and a belief in the power of chemical manipulation rather than the power of character…

Now is the time for an independent and accountable anti-doping agency, nationally and internationally, built on a best-practices model with topnotch due process protections and broad stakeholder input, especially from athletes…

New doping control measures must be rooted in sport ethics and values; they must flow from athlete agreement; they must respect athletes’ rights to privacy; and they must be independently, accountably and fairly administered…

We need to use drug-free athletes as role models and to marshal the force of parents and the media…

When it comes to eliminating doping in sports, there can be no compromise, no middle ground, not rhetorical acrobatics. We must go for the gold. Our athletes and the public deserve no less.”

Prepared Statement for the hearing on “Effects of Performance Enhancing Drugs on the Health of Athletes and Athletic Competition,” before the US Senate Committee on Commerce, Science, and Transportation, Oct. 20, 1999

Involvement and Affiliations:
  • Chairman, Prohibited List and Methods Sub-Committee, World Anti-Doping Agency (WADA), 2000-present
  • Clinical Associate Professor of Medicine, School of Medicine, New York University
  • Chairman, Medical Advisory Board, American Ballet Theatre, 2006-present
  • Chairman, Public Information and Communication Committee, American College of Sports Medicine, 2006-present
  • Chairman, Advisory Board, Taylor Hooton Foundation, 2005-present
  • Medical Advisor, White House Office of National Drug Control Policy (ONDCP), 1999-present
  • Expert witness in anabolic steroid prosecutions for the US Department of Justice, 1991-present
  • Member, Working Group on Anti-Doping Costs, WADA, 2006
  • Member, Anti-Doping Tennis Tribunals, 2004-2006
  • Substance Abuse Advisor, National Basketball Association (NBA), 2000-2006
  • Member, Health, Medicine and Research Committee, WADA, 2000-2003
  • Member, Therapeutic Use Exemptions Sub-Committee, WADA, 2000-2003
  • Co-Director, Banbury Conference on Genetic Enhancement and Doping, Cold Springs Harbor Laboratory, WADA, 2002
  • Consultant, Blue Shield and Blue Cross of America (Dietary Supplements), 2000-2001
  • Member, Technical Advisory Group, National Center on Addiction and Substance Abuse (CASA), National Commission on Sports and Substance Abuse, Columbia University, 1999-2000
  • Conferee, Conference on the Impact of National Steroid Control Legislation in the United States, US Department of Justice, 1995
  • US Representative to international meetings on research initiatives, education, and prevention strategies in drugs and sport for the World Health Organization, 1993-1994
  • MD, Cornell University Medical College
  • BS, Chemistry, Brooklyn College
  • Attended Samuel Tilden High School
  • Maintains a private practice in Internal Medicine and Sports Medicine in Manhasset, New York
  • Selected by the Institute for International Sport as “One of the 100 Most Influential Sports Educators in America,” 2007
  • Recipient, President’s Prize (Samaranch Award), International Olympic Committee (IOC), 1993
  • Official Tournament Physician, US Open Tennis Championships, 1980-1991
  • Fellow, American College of Physicians (FACP)
  • Fellow, American College of Sports Medicine (FACSM)
  • Fellow, American College of Preventive Medicine (FACPM)
  • Fellow, American College of Clinical Pharmacology (FCP)
Quoted in:
  1. Should Stimulants Use Be Accepted in Sports?
  2. Should Human Growth Hormone (HGH) Use Be Accepted in Sports?
  3. Should Performance-Enhancing Drugs Be Accepted in Sports?